Discovery of thiazolyl-phthalazinone acetamides as potent glucose uptake activators via high-throughput screening

Bioorg Med Chem Lett. 2013 Oct 15;23(20):5740-3. doi: 10.1016/j.bmcl.2013.07.067. Epub 2013 Aug 7.

Abstract

With the aim to discover orally active small molecules that stimulate glucose uptake, high throughput screening of a library of 5000 drug-like compounds was conducted in differentiated skeletal muscle cells in presence of insulin. N-Substituted phthalazinone acetamide was identified as a potential glucose uptake modulator. Several novel derivatives were synthesized to establish structure activity relationships. Identified lead thiazolyl-phthalazinone acetamide (7114863) increased glucose uptake (EC50 of 0.07±0.02 μM) in differentiated skeletal muscle cells in presence of insulin. Furthermore, 7114863 was superior to rosiglitazone under similar experimental conditions without inducing PPAR-γ agonist activity thus making it a very interesting scaffold.

Keywords: Glucose uptake activators; Obesity; PPAR-γ; Thiazolyl-phthalazinone acetamides; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / chemical synthesis
  • Acetamides / chemistry*
  • Acetamides / pharmacology
  • Animals
  • Cell Line
  • Chlorocebus aethiops
  • Drug Evaluation, Preclinical
  • Glucose / metabolism
  • High-Throughput Screening Assays
  • Humans
  • Hypoglycemic Agents
  • Insulin / pharmacology
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / drug effects
  • PPAR gamma / agonists
  • PPAR gamma / metabolism
  • Phthalazines / chemical synthesis
  • Phthalazines / chemistry*
  • Phthalazines / pharmacology
  • Structure-Activity Relationship
  • Thiazoles / chemical synthesis
  • Thiazoles / chemistry*
  • Thiazoles / pharmacology

Substances

  • 2-(3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)-N-(4-phenylthiazol-2-yl)acetamide
  • Acetamides
  • Hypoglycemic Agents
  • Insulin
  • PPAR gamma
  • Phthalazines
  • Thiazoles
  • Glucose